Evidence map›Paper›PMID 26828140›Full record

ArticleClinical nuclear medicine2016

Rapidly Growing Chest Wall Mass in a Case of Sporadic Metastatic Paraganglioma: Imaging With 4 Different PET Radiopharmaceuticals.

Ingo Janssen, Paraskevi Xekouki, Joan Nambuba, Clara C Chen, Peter Herscovitch, Corina M Millo, David S Schrump, Karel Pacak

Open access · greenAbstract readCase Reports
In one paragraph

Article in Clinical nuclear medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ingo JanssenFrom the *Program in Adult and Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, †Nuclear Medicine Division, Radiology and Imaging Sciences, Warren Grant Magnuson Clinical Center, and ‡Positron Emission Tomography Department, National Institutes of Health Clinical Center, National Institutes of Health; and §Center for Cancer Research, National Cancer Institute, Thoracic and Gastrointestinal Oncology Branch, Bethesda, MD.
Paraskevi Xekouki
Joan Nambuba
Clara C Chen
Peter Herscovitch
Corina M Millo
David S Schrump
Karel Pacak
Committee on Publication Ethics · GBEunice Kennedy Shriver National Institute of Child Health and Human Development · US

Funding

Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and ParagangliomaZIAHD008735 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI PACAK, KAREL · 2009 to 2024
$28.4M
TGIB Surgical Consultative ServicesZIDBC011541 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHRUMP, DAVID · 2014 to 2018
$12.8M
Intramural NIH HHS ZIA HD008735
6 · The paper itself

Abstract

Pheochromocytomas/paragangliomas (PGLs) are rare tumors and mostly benign. We report on a 32-year-old woman with metastatic PGL who was first diagnosed with an abdominal PGL at the age of 12 years. She soon developed metastatic disease and received several treatments including external beam radiation and chemotherapy. When she was referred to our institution in 2014, her major complaint was a rapidly growing chest wall mass on the left side. The patient was imaged at our institution with 4 different PET radiopharmaceuticals.

Indexed as

Positron-Emission TomographyRadiopharmaceuticalsAdultFemaleHumansNeoplasm MetastasisParagangliomaThoracic WallRadiopharmaceuticals

Identifiers

PMID26828140
PMCPMC4823168
OpenAlexW2312611045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.